StillCanna Announces OTC Markets Listing

VANCOUVERMay 31, 2019 /CNW/ – StillCanna Inc. (CSE:STIL) (OTC:SCNNF) (“StillCanna” or the “Company”) is pleased to announce that it is trading on the OTC Markets under the symbol “SCNNF” and its shares are DTC Eligible. StillCanna’s shares are also quoted on the Börse Frankfurt Exchange in Germany under the symbol “A2PEWA” in addition to the Canadian Securities Exchange (CSE) under the symbol “STIL”.

“Trading on the US OTC Markets will assist us with increasing our U.S. shareholder base and investor awareness as we complete our transition into producing high-quality CBD Isolate from our production centres in Romania and Poland,” stated Jason Dussault, Chief Executive Officer, “having recently announced a C$36 million supply agreement with a leading US-based producer of CBD-infused products, we look to increase our visibility with both US customers and shareholders alike.”

What is DTC Eligibility?

DTC Eligibility means that a public company’s securities are able to be deposited through DTC.  DTC is the largest securities depository in the world and holds over $35 trillion dollars’ worth of securities on deposit. DTC accepts deposits of securities from its participants only, who are usually clearing firms. Most brokers clear stock in-house or hire a clearing firm to do so on their behalf. All movements of securities are made to the participant’s account electronically with book-entry adjustments. If an issuer is not DTC eligible, then its shares cannot be transferred between brokerage accounts electronically, which means its shares cannot be traded easily.

About StillCanna Inc.

StillCanna Inc. (CSE:STIL) (OTC:SCNNF) is a Canadian early-stage life sciences company focused on large scale CBD extraction in Europe.  The Company believes its proprietary intellectual property allows it to extract CBD at a lower cost. The Company has signed an initial extraction contract in Europe to be the exclusive extractor for Dragonfly BioSciences LLC, a United Kingdom-based supplier of CBD. The Company also recently completed the acquisition of Olimax NT SP. Z .O.O, which is expected to increase the Company’s market share in the European CBD industry. 

The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.

SOURCE StillCanna Inc.

Please See Disclaimer


1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) The Article was issued on behalf of a third party, StillCanna Inc. Market Jar Media Inc. has or expects to receive sixty nine thousand canadian dollars from StillCanna Inc.’s agency of record Native Ads Inc. for 15 campaign days (10 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.’s terms of use and full legal disclaimer as set forth here.. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.